Skip to content
Research Article Open access CC BY 4.0

Post-lobectomy Hypothyroidism: Incidence and Risk Factors

Luis Mauricio Hurtado-López, Oscar Alfaro-Zebadúa

Journal of Advances in Medicine and Medical Research · pp. 158–163 · Published 15 Dec 2014

10.9734/BJMMR/2015/15100

Abstract

Background: Risk factors for developing hypothyroidism after hemithyroidectomy have not been sufficiently studied and the incidence of this complication has probably been underestimated. One factor that has been associated is the autoimmune thyroiditis but hypothyroidism is a normal occurrence in the natural course of this disease and is independent of the surgical approach. Methods: Study cohort of patients subjected to thyroid lobectomy secondary to benign (non autoimmune) thyroid disease with a minimal 4-year postsurgical follow-up. Independent variables studied were age, gender, nutritional status as expressed by body mass index (BMI), and TSH levels, and the dependent variable was development or not of hypothyroidism. Incidence and relative risk for each variable were studied. Results: We included 179 patients, 164 women with a mean age of 41.9 years and 15 men with a mean age of 40.6 years. Pathological substrates were nodular colloid goiter in 115 cases, follicular adenoma in 33 cases, adenomatous colloid goiter in 26 cases, and simple cyst in 5 cases. Sixty-seven (37.4%) patients developed hypothyroidism, 45 (67.2%) of these cases within the first 6 weeks of surgery and 22 (32.8%) cases at 6-month follow-up. No further cases of hypothyroidism were identified after 6 months and up to a mean follow- up of 4 years. The only risk factor associated was a preoperative BMI over 25. Conclusion: For patients undergoing lobectomy for a benign non-autoimmune thyroid disease and a BMI over 25, there is a 1.8-fold higher risk of developing hypothyroidism. The incidence of hypothyroidism in patients undergoing hemithyroidectomy is 37.4% and occurs in the first 6 months after surgery.

Thyroidectomy hemithyroidectomy lobectomy incidence

References (26)

  1. 1 Obesity : Preventing and managing the global epidemic
  2. 2 Subclinical thyroid disease [DOI]
  3. 3 Levothyroxine Therapy in Patients with Thyroid Disease [DOI]
  4. 4 Thyroid hormone replacement after thyroid lobectomy [DOI]
  5. 5 Hypothyroidisim following hemithyroidectomy: Incidence, risk factors, and management [DOI]
  6. 6 Hypothyroidism Following Hemithyroidectomy [DOI]
  7. 7 Risk Factors for the Development of Hypothyroidism After Hemithyroidectomy [DOI]
  8. 8 Thyroid Function After Unilateral Total Lobectomy [DOI]
  9. 9 Prediction of hypothyroidism after hemithyroidectomy: a biochemical and pathological analysis [DOI]
  10. 10 Detection and Management of Hypothyroidism Following Thyroid Lobectomy: Evaluation of a Clinical Algorithm [DOI]
  11. 11 Hemithyroidectomy for benign thyroid disease: who needs follow‐up for hypothyroidism? [DOI]
  12. 12 Is Routine Thyroxine Treatment to Hinder Postoperative Recurrence of Nontoxic Goiter Justified? [DOI]
  13. 13 Hypothyroidism following Hemithyroidectomy for Benign Nontoxic Thyroid Disease [DOI]
  14. 14 Subclinical Hypothyroidism following Hemithyroidectomy: A Simple Risk-Scoring System Using Age and Preoperative Thyrotropin Level [DOI]
  15. 15 Surveillance and Intervention After Thyroid Lobectomy [DOI]
  16. 16 Levothyroxine replacement therapy after thyroid surgery.
  17. 17 Factors Predicting the Occurrence of Hypothyroidism After Hemithyroidectomy [DOI]
  18. 18 Preventive effect of levothyroxine in patients operated for non‐toxic goitre: a randomized trial of one hundred patients with nine years follow‐up [DOI]
  19. 19 THE LONG‐TERM OUTCOME OF THYROIDECTOMY FOR SPORADIC NON‐TOXIC GOITRE [DOI]
  20. 20 Indications for thyroxine therapy after surgery for nontoxic benign goitre.
  21. 21 Long‐term follow‐up of contralateral lobe in patients hemithyroidectomized for solitary follicular adenoma [DOI]
  22. 22 Does Unilateral Lobectomy Suffice to Manage Unilateral Nontoxic Goiter? [DOI]
  23. 23 Levothyroxine Therapy in Patients with Thyroid Disease [DOI]
  24. 24 RECURRENCE OF NONTOXIC GOITRE WITH AND WITHOUT POSTOPERATIVE THYROXINE MEDICATION [DOI]
  25. 25 Nodular goiter—Is thyroxine medication of any value? [DOI]
  26. 26 Nodular goiter: Effects of surgery and thyroxine medication [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

36

Page views

0

PDF downloads

12

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.